3-oxyanthranilic acid
structure
Networked: 3
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Neoplasms (Cancer)
01/01/1976
- " The results of studies of the antigen containing 3-oxyanthranilic acid (3-OAA-antigen), as one of determinantal groups, in blood serum of patients with tumor and pretumor lesions of the stomach indicated that the former is present in the majority of patients with cancer proved histologically and also in some patients with pretumor diseases of the stomach. " 01/01/1976
- " The results of study of an unusual antigen containing carcinogenic triptophan metabolite - 3-oxyanthranilic acid as a haptene (3-OAA-antigen) in blood serum of patients with colonic and rectal tumors indicated that it is present in the majority of patients with histologically proved cancer of the large intestine in different stages, as well as in some patients with polyps of the large intestine. " 01/01/1983
- " Suggested as tumor-specific markers for colon carcinomas are an altered mucoprotein, basic antigen, beta 2-microglobulin-associated antigen, and a specific adenosine deaminase; for gastric carcinomas, a specific protein, an antigen with 3-oxyanthranilic acid, and an antigen of unknown origin in gastric secretions; for pancreatic carcinomas, an antigen with molecular weight of 380,000 daltons and an antigen suggested by tumor immunity."
|
2. | Rectal Neoplasms (Rectal Cancer)
|
3. | Polyps
|
4. | Stomach Neoplasms (Stomach Cancer)
|
5. | Pancreatic Neoplasms (Pancreatic Cancer)
|
|
Related Drugs and Biologics